| Symbol |
Name |
Standardized Value |
|
TOP1
|
topoisomerase (DNA) I
|
1.30139
|
|
FBLL1
|
fibrillarin-like 1
|
1.16606
|
|
PYHIN1
|
pyrin and HIN domain family, member 1
|
1.05177
|
|
CENPB
|
centromere protein B, 80kDa
|
0.874919
|
|
CENPC
|
centromere protein C
|
0.784345
|
|
COL1A2
|
collagen, type I, alpha 2
|
0.780251
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
0.741923
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
0.706351
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
0.705144
|
|
CTGF
|
connective tissue growth factor
|
0.697911
|
|
COL1A1
|
collagen, type I, alpha 1
|
0.694301
|
|
TGFB1
|
transforming growth factor, beta 1
|
0.689893
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
0.673917
|
|
CYCS
|
cytochrome c, somatic
|
0.673917
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
0.663975
|
|
ACE
|
angiotensin I converting enzyme
|
0.631205
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
0.608104
|
|
EDN2
|
endothelin 2
|
0.590948
|
|
S100A7
|
S100 calcium binding protein A7
|
0.585497
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
0.55945
|
|
SDC4
|
syndecan 4
|
0.53928
|
|
AIM2
|
absent in melanoma 2
|
0.53657
|
|
EDN1
|
endothelin 1
|
0.533475
|
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
0.531928
|
|
SPAG9
|
sperm associated antigen 9
|
0.528449
|
|
WDR11
|
WD repeat domain 11
|
0.505739
|
|
SETD1A
|
SET domain containing 1A
|
0.482844
|
|
TSKU
|
tsukushi, small leucine rich proteoglycan
|
0.456732
|
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa
|
0.416521
|
|
SOD1
|
superoxide dismutase 1, soluble
|
0.416147
|
|
FBN2
|
fibrillin 2
|
0.37555
|
|
THBD
|
thrombomodulin
|
0.359289
|
|
ICAM1
|
intercellular adhesion molecule 1
|
0.358183
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
0.356709
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
0.35082
|
|
SELE
|
selectin E
|
0.341639
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
0.332487
|
|
OSM
|
oncostatin M
|
0.324823
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
0.311739
|
|
EDN3
|
endothelin 3
|
0.304864
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
0.277584
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
0.254183
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
0.252422
|
|
CTSG
|
cathepsin G
|
0.244345
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
0.230063
|
|
TRIM21
|
tripartite motif containing 21
|
0.229024
|
|
RAG2
|
recombination activating gene 2
|
0.224196
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
0.220424
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
0.213621
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
0.209583
|
|
MMP1
|
matrix metallopeptidase 1
|
0.206248
|
|
CTSL
|
cathepsin L
|
0.205916
|
|
FBN1
|
fibrillin 1
|
0.201308
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
0.200331
|
|
SP1
|
Sp1 transcription factor
|
0.197099
|
|
PPT1
|
palmitoyl-protein thioesterase 1
|
0.180367
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
0.170789
|
|
HLA-DQB3
|
major histocompatibility complex, class II, DQ beta 3
|
0.163523
|
|
CTSK
|
cathepsin K
|
0.159302
|
|
IL13
|
interleukin 13
|
0.158266
|
